Browse By:

Search News Room

News Room: Biotech

Type 2 Diabetes in Youth Progresses Faster, More Aggressively Than in Adults, Even Under Optimal Treatment Conditions

ALEXANDRIA, VA--(Marketwired - May 23, 2013) - Even when they receive the best currently available treatment and close monitoring of their condition, American youth with type 2 diabetes...(more)

American Diabetes Association
May 23, 2013 15:00 ET

BIOTRONIK annonce la finalisation du recrutement pour l'étude IMPACT

BERLIN--(Marketwired - May 23, 2013) - BIOTRONIK, un fabricant de premier plan de technologies médicales novatrices, a annoncé aujourd'hui que le recrutement pour la très attendue étude IMPACT...(more)

BIOTRONIK SE. Co. KG
May 23, 2013 12:15 ET

Novo Nordisk A/S : Novo Nordisk reports 8% weight loss in phase 3a obesity trial with liraglutide 3 mg

BAGSVAERD, DENMARK--(Marketwired - May 23, 2013) - Company announcement No 39 2013: http://hugin.info/2013/R/1704259/563495.pdf This announcement is distributed by Thomson Reuters on behalf of...(more)

Novo Nordisk A/S
May 23, 2013 11:59 ET

College of Pharmacy Partners With TNI BioTech to Develop New Drugs for Africa

WASHINGTON, DC--(Marketwired - May 23, 2013) - Howard University College of Pharmacy has signed a multi-year agreement with TNI BioTech, Inc. (OTCQB: TNIB), a Bethesda, Md., biotech firm that...(more)

TNI BioTech, Inc.
May 23, 2013 09:56 ET

BrainStorm Announces CEO Interview With The Wall Street Analyst

NEW YORK, NY and PETACH TIKVAH, ISRAEL--(Marketwired - May 23, 2013) - BrainStorm Cell Therapeutics (OTCQB: BCLI), a leading developer of adult stem cell technologies for neurodegenerative...(more)

BrainStorm Cell Therapeutics, Inc.
May 23, 2013 09:52 ET

Cynapsus Therapeutics Reports First Quarter 2013 Financial Results and Recent Developments

TORONTO, ONTARIO--(Marketwired - May 23, 2013) - Cynapsus Therapeutics Inc. (TSX VENTURE:CTH), developing the only non-injectable (i.e. sublingual) delivery of the only approved drug...(more)

Cynapsus Therapeutics Inc.
May 23, 2013 09:28 ET

Patientenrekrutierung in BIOTRONIK IMPACT Studie abgeschlossen

BERLIN--(Marketwired - May 23, 2013) - BIOTRONIK, ein führender Hersteller innovativer Medizintechnik, gab heute den Abschluss der Rekrutierung in die IMPACT Studie bekannt. Ziel der Studie ist...(more)

BIOTRONIK SE. Co. KG
May 23, 2013 09:00 ET

BIOTRONIK Announces Completion of Enrollment in IMPACT Study to Investigate Stroke Risk Reduction in Patients With Atrial Fibrillation

BERLIN--(Marketwired - May 23, 2013) - BIOTRONIK, a leading manufacturer of innovative medical technology, announced today that enrollment has been completed for the highly anticipated IMPACT...(more)

BIOTRONIK SE. Co. KG
May 23, 2013 09:00 ET

Atossa Genetics to Exhibit Its ForeCYTE Breast Health Test at the 2013 ASCO Annual Meeting

SEATTLE, WA--(Marketwired - May 23, 2013) - Atossa Genetics, Inc. (NASDAQ: ATOS), The Breast Health Company™, will display its ForeCYTE Breast Health Test at the 2013 American Society of...(more)

Atossa Genetics, Inc.
May 23, 2013 08:30 ET

Un nouveau rapport confirme que les investissements de l'industrie pharmaceutique innovatrice au Canada sont systématiquement sous-évalués

OTTAWA, ONTARIO--(Marketwired - 23 mai 2013) - Pour la troisième année consécutive, une étude de KPMG commandée par Rx&D - Les compagnies de recherche pharmaceutique du Canada, a...(more)

Les compagnies de recherche pharmaceutique du Canada
May 23, 2013 08:12 ET

US: 1.800.774_.9473
Canada: 1.888.299_.0338
UK: +44.20.7220_.4500

Follow Marketwired